Press Release: Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology
Facebook
Facebook
Twitter
Twitter
LinkedIn
LinkedIn
Elsevier<%2Fa>,%20a%20world-leading%20provider%20of%20scientific,%20technical%20and%20medical%20information%20products%20and%20services,%20announced%20today%20the%20acquisition%20of InferMed<%2Fa>,%20a%20London-based%20clinical%20decision%20support%20(CDS)%20technology%20company.%0D%0A%0D%0Ahttps%3A%2F%2Fwww.bookbusinessmag.com%2Farticle%2Felsevier-acquires-infermed-provider-clinical-decision-support-technology%2F" target="_blank" class="email" data-post-id="19565" type="icon_link">
Email
Email
0 Comments
Comments
About InferMed
Launched in 1999 as a joint venture with the UK's largest cancer charity, CRUK, InferMed has become a leader in providing software and services to the healthcare, pharmaceutical, and clinical research sectors with whom it works in close collaboration. InferMed offers innovative software solutions for collecting and managing data. Through both its MACRO EDC application and Arezzo® decision support technology, InferMed's products are designed to improve patient outcomes and help healthcare providers to practise more efficiently.
0 Comments
View Comments
- People:
- Jay Katzen
- Robert Dunlop
- Places:
- London
- PHILADELPHIA, PA
- UK
Related Content
Comments